Towards developing standardized protocols for evaluation of cellular mucosal immune responses - Recommendations from a DAIDS/NIH workshop, June 15-16, 2009

Vaccine

Volumn 28, Issue 30, 2010, Pages 4689-4694

  Mehra, V ^a   Musib, R ^a   Schito, M L ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

HIV SIV; Mucosal immunity; Systems biology

Indexed keywords

CELL ASSAY; CELL ISOLATION; CELL TYPE; CELLULAR IMMUNITY; CLONAL VARIATION; CONFERENCE PAPER; DISEASE MARKER; FEMALE GENITAL SYSTEM; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL TRACT; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE; MEDICAL LITERATURE; MEDICAL RESEARCH; METHODOLOGY; MUCOSAL IMMUNITY; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; SAMPLING; STATISTICAL ANALYSIS; T LYMPHOCYTE; UTERINE CERVIX MUCOSA; VAGINA MUCOSA; FEMALE; IMMUNOLOGY; MALE; MUCOSA; NATIONAL HEALTH ORGANIZATION; UNITED STATES;

FEMALE; HIV INFECTIONS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, MUCOSAL; MALE; MUCOUS MEMBRANE; NATIONAL INSTITUTES OF HEALTH (U.S.); UNITED STATES;

EID: 77954219377     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.04.092     Document Type: Conference Paper

References (22)

1. Anton P.A., Ibarrondo F.J., Boscardin W.J., Zhou Y., Schwartz E.J., Ng H.L., et al. Differential immunogenicity of vaccinia and HIV-1 components of a human recombinant vaccine in mucosal and blood compartments. Vaccine 2008, 26:4617-4623.
2. Pala P., Gomez-Roman V.R., Gilmour J., Kaleebu P. An African perspective on mucosal immunity and HIV-1. Mucosal Immunol 2009, 2:300-314.
3. Girard M.P., Bansal G.P., Pedroza-Martins L., Dodet B., Mehra V., Schito M., et al. Mucosal immunity and HIV/AIDS vaccines. Report of an International Workshop, 28-30 October 2007. Vaccine 2008, 26:3969-3977.
4. Haase A.T. Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol 2005, 5:783-792.
5. Shacklett B.L., Yang O., Hausner M.A., Elliott J., Hultin L., Price C., et al. Optimization of methods to assess human mucosal T-cell responses to HIV infection. J Immunol Methods 2003, 279:17-31.
6. McGowan I., Elliott J., Cortina G., Tanner K., Siboliban C., Adler A., et al. Characterization of baseline intestinal mucosal indices of injury and inflammation in men for use in rectal microbicide trials (HIV Prevention Trials Network-056). J Acquir Immune Defic Syndr 2007, 46:417-425.
7. Anton P., Elliott J., Tanner K., Cho D., Johnson E., Zhou Y., et al. Strong suppression of HIV-1 infection of colorectal explants following in vivo rectal application of UC781 gel: a novel endpoint in a phase I trial. 16th conference on retroviruses and opportunistic infections (CROI) 2009.
8. Shacklett B.L., Critchfield J.W., Lemongello D. Isolating mucosal lymphocytes from biopsy tissue for cellular immunology assays. Methods Mol Biol 2009, 485:347-356.
9. Zhu J., Hladik F., Woodward A., Klock A., Peng T., Johnston C., et al. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med 2009, 15:886-892.
10. Nkwanyana N.N., Gumbi P.P., Roberts L., Denny L., Hanekom W., Soares A., et al. Impact of human immunodeficiency virus 1 infection and inflammation on the composition and yield of cervical mononuclear cells in the female genital tract. Immunology 2009, 128:e746-e757.
11. Bere A., Denny L., Hanekom W., Burgers W.A., Passmore J.A. Comparison of polyclonal expansion methods to improve the recovery of cervical cytobrush-derived T cells from the female genital tract of HIV-infected women. J Immunol Methods 2010, 354:68-79.
12. Demberg T., Robert-Guroff M. Mucosal immunity and protection against HIV/SIV infection: strategies and challenges for vaccine design. Int Rev Immunol 2009, 28:20-48.
13. Spidlen J., Leif R.C., Moore W., Roederer M., Brinkman R.R. Gating-ML: XML-based gating descriptions in flow cytometry. Cytometry A 2008, 73A:1151-1157.
14. Roederer M. How many events is enough? Are you positive?. Cytometry A 2008, 73:384-385.
15. Critchfield J.W., Young D.H., Hayes T.L., Braun J.V., Garcia J.C., Pollard R.B., et al. Magnitude and complexity of rectal mucosa HIV-1-specific CD8+ T-cell responses during chronic infection reflect clinical status. PLoS One 2008, 3:e3577.
16. Wang H.C., Zhou Q., Dragoo J., Klein J.R. Most murine CD8+ intestinal intraepithelial lymphocytes are partially but not fully activated T cells. J Immunol 2002, 169:4717-4722.
17. Masopust D., Vezys V., Wherry E.J., Barber D.L., Ahmed R. Cutting edge: gut microenvironment promotes differentiation of a unique memory CD8 T cell population. J Immunol 2006, 176:2079-2083.
18. Wang X., Xu H., Gill A.F., Pahar B., Kempf D., Rasmussen T., et al. Monitoring alpha4beta7 integrin expression on circulating CD4+ T cells as a surrogate marker for tracking intestinal CD4+ T-cell loss in SIV infection. Mucosal Immunol 2009, 2:518-526.
19. Story C.M., Papa E., Hu C.C., Ronan J.L., Herlihy K., Ploegh H.L., et al. Profiling antibody responses by multiparametric analysis of primary B cells. Proc Natl Acad Sci USA 2008, 105:17902-17907.
20. Pulendran B. Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology. Nat Rev Immunol 2009, 9:741-747.
21. Gaucher D., Therrien R., Kettaf N., Angermann B.R., Boucher G., Filali-Mouhim A., et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med 2008, 205:3119-3131.
22. Querec T.D., Akondy R.S., Lee E.K., Cao W., Nakaya H.I., Teuwen D., et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 2009, 10:116-125.